X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (92) 92
hematology (57) 57
index medicus (50) 50
female (37) 37
male (36) 36
hereditary thrombocythemia (31) 31
mutation (30) 30
oncology (26) 26
adult (24) 24
child (22) 22
polycythemia-vera (22) 22
middle aged (21) 21
genetic aspects (20) 20
thrombopoietin - genetics (18) 18
thrombocytosis - genetics (17) 17
thrombopoietin gene (17) 17
adolescent (16) 16
aged (15) 15
child, preschool (15) 15
risk factors (15) 15
thrombopoietin (15) 15
familial essential thrombocythemia (14) 14
pedigree (14) 14
c-mpl (13) 13
congenital, hereditary, and neonatal diseases and abnormalities (13) 13
disease (13) 13
splice donor mutation (13) 13
essential thrombocythemia (12) 12
hemic and lymphatic diseases (11) 11
myeloproliferative disorders (11) 11
receptors, thrombopoietin - genetics (11) 11
thrombocytosis (11) 11
tyrosine kinase jak2 (11) 11
animals (10) 10
article (10) 10
base deletion (10) 10
cancer (10) 10
gene mutations (10) 10
genetics (10) 10
myeloproliferative neoplasms (10) 10
causes hereditary thrombocythemia (9) 9
diagnosis (9) 9
diseases (9) 9
gene (9) 9
genetic predisposition to disease (9) 9
genetics, medical (9) 9
hereditary diseases (9) 9
hereditary thrombocytosis (9) 9
infant (9) 9
janus kinase 2 - genetics (9) 9
medicine & public health (9) 9
biochemistry & molecular biology (8) 8
genetic diseases, inborn (8) 8
genetic disorders (8) 8
leukemia (8) 8
medical genetics (8) 8
phenotype (8) 8
research (8) 8
thrombocythemia, essential - genetics (8) 8
abridged index medicus (7) 7
aged, 80 and over (7) 7
care and treatment (7) 7
disorders (7) 7
expression (7) 7
health aspects (7) 7
jak2 (7) 7
pediatrics (7) 7
polycythemia vera - genetics (7) 7
proteins (7) 7
thrombopoietin - blood (7) 7
thrombopoietin - metabolism (7) 7
thrombosis (7) 7
young adult (7) 7
genes (6) 6
génétique médicale (6) 6
hereditary hemorrhagic telangiectasia (6) 6
medische genetica (6) 6
mutations (6) 6
myelofibrosis (6) 6
myeloproliferative disorders - genetics (6) 6
point mutation (6) 6
polycythemia (6) 6
review (6) 6
thrombocythemia, essential - diagnosis (6) 6
acute myeloid-leukemia (5) 5
anemia (5) 5
bone-marrow (5) 5
classification (5) 5
clinical genetics (5) 5
dna mutational analysis (5) 5
erythropoietin receptor (5) 5
gene expression (5) 5
genetic research (5) 5
genética médica (5) 5
germ-line mutation (5) 5
hematologic neoplasms - genetics (5) 5
hematology, oncology and palliative medicine (5) 5
hereditary spherocytosis (5) 5
heredity of disease (5) 5
medicine (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
UofT at Scarborough - Sunnybrook Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 03/2007, Volume 25, Issue 9, pp. 1048 - 1053
Purpose Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile... 
V617F MUTATION | FAMILIAL ESSENTIAL THROMBOCYTHEMIA | RUBRA VERA | OVEREXPRESSION | HEREDITARY THROMBOCYTHEMIA | ONCOLOGY | PRV-1 | TYROSINE KINASE JAK2 | DISORDERS | THROMBOPOIETIN GENE | BASE DELETION | Follow-Up Studies | Humans | Middle Aged | GPI-Linked Proteins | Polycythemia Vera - blood | Male | Polycythemia Vera - genetics | Thrombocythemia, Essential - pathology | Thrombocythemia, Essential - genetics | Thrombopoietin - blood | Myeloproliferative Disorders - genetics | Receptors, Erythropoietin - genetics | Incidence | Myeloproliferative Disorders - blood | Polycythemia Vera - complications | Time Factors | Aged, 80 and over | Adult | Female | Polycythemia Vera - pathology | Child | Receptors, Androgen - blood | Isoantigens - genetics | Janus Kinase 2 - genetics | Membrane Glycoproteins - blood | Receptors, Cell Surface - blood | Thrombosis - epidemiology | Biomarkers - blood | Thrombocythemia, Essential - blood | Membrane Glycoproteins - genetics | Rome - epidemiology | Erythroid Precursor Cells - pathology | Isoantigens - blood | Receptors, Thrombopoietin - genetics | Thrombopoietin - genetics | RNA, Messenger - blood | Receptors, Androgen - genetics | Pedigree | Thrombosis - etiology | Adolescent | Receptors, Erythropoietin - blood | Aged | Mutation | Janus Kinase 2 - blood | Receptors, Thrombopoietin - blood | Cohort Studies | Receptors, Cell Surface - genetics | Thrombocythemia, Essential - complications
Journal Article
Journal Article
JAK-STAT, ISSN 2162-3988, 07/2014, Volume 3, Issue 3, p. e957618
Acquired mutations of the gene that encodes the intracellular signalling molecule JAK2 are the most frequently observed disease-driving events of the common... 
hereditary thrombocythemia | mutations | germline | JAK2 | therapy
Journal Article